Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

How should I calculate and assess the return on investment (ROI) for my pharmaceutical business?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q276 · Category F: Fees, budgeting and financial planning (Q251–Q300)
Calculating and assessing the return on investment (ROI) for a pharmaceutical business is key to measuring the success of your investment. The basic formula is: ROI = (annual net profit / total investment cost) x 100%. ‘Annual net profit’ is your annual total income after deducting all operating costs, including the cost of goods, rent, salaries and taxes. ‘Total investment cost’ is the total amount of funds invested in starting and operating the business, including licence applications, renovations, equipment, consultancy fees and initial working capital. A healthy pharmaceutical business should have an ROI significantly higher than a risk-free return (such as the interest rate on bank deposits) to compensate for the business risks you take and the effort you invest.

📘 Regulatory basis

Although no regulation directly prescribes a specific ROI, a business that consistently makes losses or generates a very low return may be unable to sustain long-term compliance investment, such as equipment upgrades and staff training, thereby indirectly creating compliance risks.

📗 Drew Tang's recommendations

When assessing ROI, we recommend looking beyond the first year and conducting a dynamic assessment over 3 to 5 years. Medicine businesses usually need time to build a customer base and market reputation, so the initial ROI may be low. Its growth trend is more important. You should also monitor other key financial indicators, such as gross margin and inventory turnover.

📕 Risk notice

When calculating ROI, the biggest pitfall is underestimating the ‘total investment cost’, particularly by overlooking the opportunity cost of the time and effort you put in yourself. A business that appears to generate a positive return may not be a wise personal financial investment if its rate of return is far below the income you could earn from other work.

Back to Category F: Fees, Budget and Financial Planning (Q251-Q300) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗